Influence of Yiqiyangyinhuoxue Decoction on ET-1 and ANGII in Patients with Diastolic Heart Failure
Bin Yu
Abstract
Bin Yu
Abstract
Objective: To examine the influence of Yiqiyangyinhuoxue Decoction on endothelin-l(ET-1) and angiotensinⅡ(ANGⅡ)in patients with diastolic heart failure(DHF).Methods: 160 patients with DHF were randomly divided into the control group and the treatment group(80 patients).The control group were treated with routine western medicine.The treatment group were treated with decoction besides the control group therapy.Results: The ET-1 and ANGⅡ of the treatment group were decreased more obviously than those of the control group.The effect of the treatment group was superior to that of the control group.Conclusion: Expressions including ET-1 and ANGⅡ are lowered remarkably when used the Yiqiyangyinhuoxue decoction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To examine the influence of Yiqiyangyinhuoxue Decoction on endothelin-l(ET-1) and angiotensinⅡ(ANGⅡ)in patients with diastolic heart failure(DHF).Methods: 160 patients with DHF were randomly divided into the control group and the treatment group(80 patients).The control group were treated with routine western medicine.The treatment group were treated with decoction besides the control group therapy.Results: The ET-1 and ANGⅡ of the treatment group were decreased more obviously than those of the control group.The effect of the treatment group was superior to that of the control group.Conclusion: Expressions including ET-1 and ANGⅡ are lowered remarkably when used the Yiqiyangyinhuoxue decoction.
Key concepts: Medicine, Decoction, Endothelin receptor, Diastolic heart failure, Heart failure, Diastole, Internal medicine, Treatment and control groups